Dixestivo
Servizo
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (4)
2023
-
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 24, Núm. 12, pp. 1399-1410
2022
-
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 2, pp. 118-127
2021
2016
-
Ustekinumab as induction and maintenance therapy for Crohn's disease
New England Journal of Medicine, Vol. 375, Núm. 20, pp. 1946-1960